|

CALR allele burden quantification Clinical Trials

1 actively recruiting trial

Top Sponsors

  • University Hospital, Angers1

Indications

  • Primary Myelofibrosis, Fibrotic Stage1
  • Primary Myelofibrosis, Prefibrotic Stage1
  • Myeloproliferative Neoplasm1
  • Essential Thrombocythemia1
  • Cancer1

Other1 trial

Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.